Granting and acceptance of share awards by directors and the company secretary of Mediclinic Mediclinic International Limited Incorporated in the Republic of South Africa Reg. no. 1983/010725/06 Income tax no: 9950122714 Share code: MDC ISIN code: ZAE000074142 (“Mediclinic” or “the Company”) GRANTING AND ACCEPTANCE OF SHARE AWARDS BY DIRECTORS AND THE COMPANY SECRETARY OF MEDICLINIC IN TERMS OF THE MEDICLINIC INTERNATIONAL LIMITED FORFEITABLE SHARE PLAN In compliance with the JSE Listings Requirements, the following executive directors of the Company have been granted and accepted conditional share awards in terms of the Mediclinic Forfeitable Share Plan on 16 September 2014, as approved by the Company’s shareholders at the annual general meeting in July 2014. Subject to meeting the performance conditions, vesting will occur on the later of 31 May 2017 or the date upon which the Remuneration and Nominations Committee is satisfied that the performance conditions have been satisfied. Director : D P Meintjes Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 79 077 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R7 395 281.04 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Director : C I Tingle Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 44 320 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R4 144 806.40 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Director : K H S Pretorius Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 31 690 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R2 963 648.80 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Director : T O Wiesinger Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 28 010 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R2 619 495.20 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Director : C A van der Merwe Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 26 411 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R2 469 956.72 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Director : G C Hattingh (Company Secretary) Company : Mediclinic International Limited Date of acceptance : 16 September 2014 Nature of transaction : Off market acceptance of conditional share awards. Number of securities : 23 575 Class of securities : Ordinary shares Consideration payable : Nil Total value of transaction : R2 204 734.00 based on the on acceptance closing price of R93.52 per share on 15 September 2014. Nature of interest : Direct beneficial Clearance obtained : Yes Stellenbosch 16 September 2014 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 16/09/2014 05:44:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.